Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats

World Journal of Gastroenterology

Volumn 19, Issue 34, 2013, Pages 5633-5644

  Al Rejaie, Salim S ^a   Abuohashish, Hatem M ^a   Al Enazi, Maher M ^b   Al Assaf, Abdullah H ^a   Parmar, Mihir Y ^a   Ahmed, Mohammed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Inflammatory bowel disease; Naringenin; Oxidative stress; Ulcerative colitis

Indexed keywords

CATALASE; GLUTATHIONE SULPHADRYLS; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESALAZINE; NARINGENIN; NITRIC OXIDE; NON PROTEIN SULPHADRYLS; PEPTIDES AND PROTEINS; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; MALE; NECROSIS; NONHUMAN; RAT; SINGLE DRUG DOSE; ULCER; ULCERATIVE COLITIS;

INFLAMMATORY BOWEL DISEASE; NARINGENIN; OXIDATIVE STRESS; ULCERATIVE COLITIS;

ACETIC ACID; ANIMALS; ANTI-ULCER AGENTS; COLITIS, ULCERATIVE; DRUG EVALUATION, PRECLINICAL; FLAVANONES; INTESTINAL MUCOSA; MALE; RATS; RATS, WISTAR;

EID: 84883850773     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i34.5633     Document Type: Article

References (67)

1. Selling JH, Pasricha PJ. Pharmacotherapy of inflammatory bowel disease. In: Gilman's G, editor. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill Publications, 2006: 1009
2. Parkes M, Jewell D. Ulcerative colitis and Crohns disease: molecular genetics and clinical implications. Expert Rev Mol Med 2001; 2001: 1-18 [PMID: 14987369]
3. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in infammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474-1482 [PMID: 22929759]
4. Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: record linkage study. World J Gastroenterol 2010; 16: 431-438 [PMID: 20101767]
5. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE. Increased oxidative stress and decreased antioxidant defenses in mucosa of infammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086 [PMID: 8888724]
6. Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, Tahan V, Uzun H. Vitamin E has a dual effect of anti-in-fammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg 2011; 54: 333-338 [PMID: 21933527 DOI: 10.1503/cjs.013610]
7. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol 2005; 11: 2371-2384 [PMID: 15832404]
8. Tüzün A, Erdil A, Inal V, Aydin A, Baǧci S, Yeşilova Z, Sayal A, Karaeren N, Daǧalp K. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002; 35: 569-572 [PMID: 12493587]
9. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 5S-11S [PMID: 9395346]
10. Bertevello PL, Logullo AF, Nonogaki S, Campos FM, Chiferi V, Alves CC, Torrinhas RS, Gama-Rodrigues JJ, Waitzberg DL. Immunohistochemical assessment of mucosal cytokine profle in acetic acid experimental colitis. Clinics (Sao Paulo) 2005; 60: 277-286 [PMID: 16138233]
11. Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol 2008; 14: 5154-5161 [PMID: 18777592]
12. Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora SJ. Therapeutic effcacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicol Environ Saf 2011; 74: 607-614 [PMID: 20719385]
13. Ortiz-Andrade RR, Sánchez-Salgado JC, Navarrete-Vázquez G, Webster SP, Binnie M, García-Jiménez S, León-Rivera I, Cigarroa-Vázquez P, Villalobos-Molina R, Estrada-Soto S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 2008; 10: 1097-1104 [PMID: 18355329]
14. Lisa J, Wilcox M, Borradaile W. Antiatherogenic Properties of Naringenin, a Citrus Flavonoid. Cardiovasc Drug Rev 1999; 17: 160-178
15. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic an-tioxidants curcumin and naringenin but not quercetin and fsetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005; 39: 1119-1125 [PMID: 16298737]
16. Jong-Hwa P, Jin-Woo L, Hyun-Dong P, Ssang-Goo C, Seung-Yeol N, Yong-Sun P, Ye-Sun H. Cytotoxic Effects of 7-O-Butyl Naringenin on Human Breast Cancer MCF-7 Cells. Food Sci Biotechnol 2010; 19: 717-724
17. Oršolić N, Gajski G, Garaj-Vrhovac V, Dikić D, Prskalo ZŠ, Sirovina D. DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur J Pharmacol 2011; 656: 110-118 [PMID: 21277296]
18. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Saw-yez CG, Edwards JY, Markle JM, Hegele RA, Huff MW. Nar-ingenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009; 58: 2198-2210 [PMID: 19592617]
19. Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit favonoid narin-genin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One 2010; 5: e12399 [PMID: 20811644 DOI: 10.1371/journal. pone.0012399]
20. Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience 2012; 226: 62-72 [PMID: 22999973]
21. Hirai S, Kim YI, Goto T, Kang MS, Yoshimura M, Obata A, Yu R, Kawada T. Inhibitory effect of naringenin chalcone on infammatory changes in the interaction between adipocytes and macrophages. Life Sci 2007; 81: 1272-1279 [PMID: 17915259]
22. InêsAmaro M, Rocha J, Vila-Real H, Eduardo-Figueira M, Mota-Filipe H, Sepodes B, Ribeiro MH. Anti-inflammatory activity of naringin and the biosynthesisednaringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res Int 2009; 42: 1010-1017 [DOI: 10.1016/j.foodres.2009.04.016]
23. Cetinkaya A, Bulbuloglu E, Kantarceken B, Ciralik H, Kuru-tas EB, Buyukbese MA, Gumusalan Y. Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Dig Dis Sci 2006; 51: 488-494 [PMID: 16614957 DOI: 10.1007/ s10620-006-3160-9]
24. Koch TR, Yuan LX, Stryker SJ, Ratliff P, Telford GL, Opara EC. Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 2000; 45: 1814-1819 [PMID: 11052325]
25. Mousavizadeh K, Rahimian R, Fakhfouri G, Aslani FS, Gha-fourifar P. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. Eur J Clin Invest 2009; 39: 375-383 [PMID: 19302562]
26. Harputluoglu MM, Demirel U, Yücel N, Karadaǧ N, Temel I, Firat S, Ara C, Aladaǧ M, Karincaoǧlu M, Hilmioǧlu F. The effects of Gingko biloba extract on acetic acid-induced colitis in rats. Turk J Gastroenterol 2006; 17: 177-182 [PMID: 16941250]
27. Kannan N, Guruvayoorappan C. Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators. Int Immu-nopharmacol 2013; 16: 57-66 [PMID: 23538025 DOI: 10.1016/ j.intimp.2013.03.008]
28. Popov SV, Markov PA, Nikitina IR, Petrishev S, Smirnov V, Ovodov YS. Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice. World J Gastroenterol 2006; 12: 6646-6651 [PMID: 17075978]
29. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205 [PMID: 4973948]
30. Aebi H. Catalase. In: Bergmeyer HV, editor. Methods in enzymatic analysis. New York: Verlag Chemie-Academic Press, 1974: 674-684
31. Kono Y. Generation of superoxide radical during autoxida-tion of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978; 186: 189-195 [PMID: 24422]
32. Bregman A. Laboratory Investigation and Cell Biology. New York: John Wiley and Sons, 1983
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275 [PMID: 14907713]
34. D'Argenio G, Mazzone G, Tuccillo C, Ribecco MT, Graziani G, Gravina AG, Caserta S, Guido S, Fogliano V, Caporaso N, Romano M. Apple polyphenols extract (APE) improves colon damage in a rat model of colitis. Dig Liver Dis 2012; 44: 555-562 [PMID: 22381211]
35. Hartmann RM, Morgan Martins MI, Tieppo J, Fillmann HS, Marroni NP. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid. Dig Dis Sci 2012; 57: 2038-2044 [PMID: 22451119 DOI: 10.1007/s10620-012-2134-3]
36. El-Abhar HS, Hammad LN, Gawad HS. Modulating effect of ginger extract on rats with ulcerative colitis. J Ethnopharmacol 2008; 118: 367-372 [PMID: 18571884]
37. Al-Rejaie SS, Abuohashish HM, Ahmed MM, Aleisa AM, Alkhamees O. Possible biochemical effects following inhibi-tion of ethanol-induced gastric mucosa damage by Gymne-ma sylvestre in male Wistar albino rats. Pharm Biol 2012; 50: 1542-1550 [PMID: 22978267 DOI: 10.3109/13880209.2012.694 894]
38. Sands BE. Therapy of infammatory bowel disease. Gastroen-terology 2000; 118: S68-S82 [PMID: 10868899]
39. Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with infammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 2002; 16: 197-205 [PMID: 11860402]
40. Sánchez de Medina F, Vera B, Gálvez J, Zarzuelo A. Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci 2002; 70: 3097-3108 [PMID: 12008093]
41. Tang Q, Fan H, Shou Z, Liu X. Study on protective mechanism of kushenin injection on colonic mucosa of experimental colitis rats. Zhongguo Zhong Yao Zazhi 2012; 37: 1814-1817 [PMID: 22997830]
42. Park MY, Ji GE, Sung MK. Dietary kaempferol suppresses in-fammation of dextran sulfate sodium-induced colitis in mice. Dig Dis Sci 2012; 57: 355-363 [PMID: 21901258 DOI: 10.1007/ s10620-011-1883-8]
43. Dai SX, Zou Y, Feng YL, Liu HB, Zheng XB. Baicalin down-regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis. Phyto-ther Res 2012; 26: 498-504 [PMID: 21887805]
44. Parmar NS. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor. Int J Tissue React 1983; 5: 415-420 [PMID: 6671888]
45. Motilva V, Alarcón de la Lastra C, Martín MJ. Ulcer-protecting effects of naringenin on gastric lesions induced by ethanol in rat: role of endogenous prostaglandins. J Pharm Pharmacol 1994; 46: 91-94 [PMID: 8021812]
46. Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in infammatory bowel disease--radi-cals or ridiculous? Aliment Pharmacol Ther 2002; 16: 1997-2015 [PMID: 12452933]
47. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95 [PMID: 11773609 DOI: 10.1152/physrev.00018.2001]
48. Closa D, Folch-Puy E. Oxygen free radicals and the systemic infammatory response. IUBMB Life 2004; 56: 185-191 [PMID: 15230345 DOI: 10.1080/15216540410001701642]
49. Isozaki Y, Yoshida N, Kuroda M, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats. Int J Mol Med 2006; 17: 497-502 [PMID: 16465398]
50. Yoshikawa T, Ueda S, Naito Y, Takahashi S, Oyamada H, Morita Y, Yoneta T, Kondo M. Role of oxygen-derived free radicals in gastric mucosal injury induced by ischemia or ischemia-reperfusion in rats. Free Radic Res Commun 1989; 7: 285-291 [PMID: 2583548]
51. Bitiren M, Karakilcik AZ, Zerin M, Ozardali I, Selek S, Na-zligül Y, Ozgonul A, Musa D, Uzunkoy A. Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats. Biol Trace Elem Res 2010; 136: 87-95 [PMID: 19774348 DOI: 10.1007/s12011-009-8518-3]
52. Ademoglu E, Erbil Y, Tam B, Barbaros U, Ilhan E, Olgac V, Mutlu-Turkoglu U. Do vitamin E and selenium have benef-cial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 2004; 49: 102-108 [PMID: 14992443]
53. Sivaprasad R, Nagaraj M, Varalakshmi P. Combined effca-cies of lipoic acid and 2,3-dimercaptosuccinic acid against lead-induced lipid peroxidation in rat liver. J Nutr Biochem 2004; 15: 18-23 [PMID: 14711456]
54. Sivaprasad R, Nagaraj M, Varalakshmi P. Lipoic acid in combination with a chelator ameliorates lead-induced peroxi-dative damages in rat kidney. Arch Toxicol 2002; 76: 437-441 [PMID: 12185410 DOI: 10.1007/s00204-002-0350-x]
55. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008; 585: 325-337 [PMID: 18417116]
56. Han XZ, Gao S, Cheng YN, Sun YZ, Liu W, Tang LL, Ren DM. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyo-cytes. Biosci Trends 2012; 6: 19-25 [PMID: 22426099]
57. Wang J, Yang Z, Lin L, Zhao Z, Liu Z, Liu X. Protective effect of naringenin against lead-induced oxidative stress in rats. Biol Trace Elem Res 2012; 146: 354-359 [PMID: 22109809 DOI: 10.1007/s12011-011-9268-6]
58. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory bowel disease. Ann N Y Acad Sci 1992; 664: 103-115 [PMID: 1456643]
59. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in infammatory bowel disease. Free Radic Biol Med 2002; 33: 311-322 [PMID: 12126753]
60. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-861 [PMID: 7916405]
61. Stucchi A, Reed K, O'Brien M, Cerda S, Andrews C, Gower A, Bushell K, Amar S, Leeman S, Becker J. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflamm Bowel Dis 2006; 12: 581-587 [PMID: 16804395 DOI: 10.1097/01.MIB.0000225338.14356.d5]
62. Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in infammatory bowel disease: evidence for involvement of TNF-alpha. Am J Physiol Gastro-intest Liver Physiol 2006; 290: G361-G368 [PMID: 16195422]
63. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001; 68: 921-931 [PMID: 11213362]
64. Yang J, Li Q, Zhou XD, Kolosov VP, Perelman JM. Narin-genin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol Cell Biochem 2011; 351: 29-40 [PMID: 21229383 DOI: 10.1007/s11010-010-0708-y]
65. Bodet C, La VD, Epifano F, Grenier D. Naringenin has anti-infammatory properties in macrophage and ex vivo human whole-blood models. J Periodontal Res 2008; 43: 400-407 [PMID: 18503517]
66. Park HY, Kim GY, Choi YH. Naringenin attenuates the release of pro-infammatory mediators from lipopolysaccha-ride-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol Med 2012; 30: 204-210 [PMID: 22552813 DOI: 10.3892/ ijmm.2012.979]
67. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moil-anen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, narin-genin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Infamm 2007; 2007: 45673 [PMID: 18274639 DOI: 10.1155/2007/45673]